Dr. Reddy's Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
DRREDDY · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Dr. Reddy's Laboratories has informed the stock exchanges that its Board of Directors will meet on Tuesday, May 12, 2026, to consider and approve the Audited Standalone and Consolidated Financial Results for the quarter and full financial year ending March 31, 2026. In line with SEBI's Insider Trading Regulations, the trading window for dealing in the company's shares will remain closed from March 25, 2026, to May 14, 2026 (both days inclusive). During this period, designated persons and their immediate relatives are prohibited from trading in the company's securities. This is a routine compliance filing and does not by itself indicate any change in business or financial performance.
No direct impact on shareholders from this announcement. Investors should note that the Q4 and FY26 audited results will be announced on or around May 12, 2026, which will be a key event for the stock. The trading window closure is a standard regulatory requirement and restricts insider trading until results are publicly disclosed.